Letter to the Editor

Issue: Ahead-of-Print Publication Date: 2023-04-13
Lack of information as a barrier to blood donation: results from a survey of pharma industry workers in Italy

Massimiliano Copetti, Carmen Di Silvio, Rosanna Mangiarotti, Alessandra Vignoli, Laura Franzini
Issue: Blood Transfusion - 2 2019 (March-April) Publication Date: 2022-12-02
A case of dabigratan-related acute agranulocytosis

Ahmad Al-Khaffaf, Francesco Frattini, Cinzia Sissa, Elda Mimiola, Massimo Franchini
Issue: Blood Transfusion - 6 2022 (November-December) Publication Date: 2022-07-22
COVID-19 vaccination, anticoagulation level and warfarin treatment

Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Issue: Blood Transfusion - 6 2022 (November-December) Publication Date: 2022-07-22
Lack of influence of SARS-CoV 2 vaccination on anticoagulation levels of patients on stable, long-term warfarin treatment

Elena Lotti, Alessandro Masi, Chiara Cappugi, Alessandra Fanelli, Lucia Mannini, Rossella Marcucci, Daniela Poli
Issue: Blood Transfusion - 6 2022 (November-December) Publication Date: 2022-07-22
Continuous population surveillance of COVID-19 immunity can be provided by Blood Services at low cost using routine laboratory infrastructure

Stephen M. Henry, Willy A. Flegel, Christof Weinstock
Issue: Ahead-of-Print Publication Date: 2022-06-07
A novel serological RhD confirmatory test for patients with warm autoimmune haemolytic anaemia with a strong positive direct antiglobulin test

Chunchen Yang, Jiewei Zheng, Ruiming Rong, Dong Xiang
Issue: Blood Transfusion - 3 2022 (May-June) Publication Date: 2021-09-22
Blood donor serological screening for SARS-CoV-2 as a tool to estimate the prevalence of asymptomatic infection in a low-intermediate endemic area of southern Italy after the first wave of the pandemic

Federica Calò, Alessandra Di Fraia, Antonio Russo, Antonio Di Biase, Saverio Misso, Nicola Coppola
Issue: Blood Transfusion - 2 2022 (March-April) Publication Date: 2021-03-30
Iron parenteral administration: an expert opinion on the assessment of fetal wellbeing

Antonio Ragusa, Alessandro Svelato, Matteo Bolcato
Issue: Blood Transfusion - 2 2022 (March-April) Publication Date: 2021-03-30
Organisational strategies for the safe management of intravenous iron therapy: a revolutionary tool for implementing Patient Blood Management

Matteo Bolcato, Ivo Beverina
Issue: Blood Transfusion - 2 2021 (March-April) Publication Date: 2020-12-23
Making friends out of foes: novel therapeutic approaches for haemophilia

Catriona Mactier, Cedric Hermans
Issue: Blood Transfusion - 2 2021 (March-April) Publication Date: 2020-12-22
Appropriate red cell transfusions are often avoidable through Patient Blood Management

Kevin M. Trentino, Hamish S. Mace, Michael F. Leahy, Frank M. Sanfilippo, Shannon L. Farmer, Kevin Murray
Issue: Blood Transfusion - 1 2021 (January-February) Publication Date: 2020-11-12
On the association between the ABO blood group and COVID-19 susceptibility

Davide Golinelli
Issue: Blood Transfusion - 1 2021 (January-February) Publication Date: 2020-10-09
Transfusion of a D-- phenotype patient using the rare blood donor registry of the Korean Red Cross Blood Services

Jay Ho Han, So-Yong Kwon, Dong Wook Jekarl
Issue: Blood Transfusion - 6 2020 (November-December) Publication Date: 2020-09-18
Haemophilia A/B carriers: haemorrhagic burden of disease and open issues

Samantha Pasca, Ezio Zanon
Issue: Blood Transfusion - 5 2020 (September-October) Publication Date: 2020-07-29
Prevalence and clinical features of COVID-19 in Iranian patients with congenital coagulation disorders

Mehran Karimi, Sezaneh Haghpanah, Amin Shahsavani
Issue: Blood Transfusion - 4 2020 (July-August) Publication Date: 2020-07-13
Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy

Daniela Dragonetti, Giuseppe Guarini, Michele Pizzuti
Issue: Blood Transfusion - 4 2020 (July-August) Publication Date: 2020-07-13
Therapeutic choices in persons with haemophilia at the time of COVID-19

Antonio Coppola, Federica Riccardi, Annarita Tagliaferri
Issue: Blood Transfusion - 3 2020 (May-June) Publication Date: 2020-05-07
Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial"

Marco Marietta, Armando Tripodi
Issue: Blood Transfusion - 3 2020 (May-June) Publication Date: 2020-05-07
A multimodal practical approach in a Transfusion Medicine Centre to face the COVID-19 outbreak

Valentino Granero, Paola M. Manzini, Anna M. Bordiga
Issue: Blood Transfusion - 3 2020 (May-June) Publication Date: 2020-05-07
Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial

Marco Cattaneo, Nuccia Morici
Issue: Blood Transfusion - 3 2020 (May-June) Publication Date: 2020-05-07
Use of eye drops obtained from homologous blood source in the time of COVID-19: is there cause for ophthalmological concern?

Giuseppe Giannaccare, Marina Buzzi, Piera Versura
Issue: Blood Transfusion - 1 2019 (January-February) Publication Date: 2018-11-07
Cost of Pathogen Reduction for platelets: reply to Cicchetti et al. Blood Transfus 2018; 16: 483-9

Albert Farrugia
Issue: Blood Transfusion - 1 2019 (January-February) Publication Date: 2018-04-04
On the cost-utility of methylene blue-photoinactivated plasma versus quarantine plasma in Spain

Arturo Pereira, Julio del Río-Garma, José A. García-Erce
Issue: Blood Transfusion - 1 2019 (January-February) Publication Date: 2017-12-22
Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis"

Andrea Messori, Flora Peyvandi, Sabrina Trippoli, Roberta Palla, Frits R. Rosendaal, Pier Mannuccio Mannucci
Issue: Blood Transfusion - 1 2019 (January-February) Publication Date: 2017-10-03
Reply to "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis" by Messori et al.

Albert Farrugia, Megha Bansal
Issue: Blood Transfusion - 1 2018 (January - February) Publication Date: 2016-09-22
Preserved in vitro metabolic and functional characteristics of double-dose apheresis platelet concentrates photochemically treated with amotosalen and ultraviolet A light

Per Sandgren

Submit an Article

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Letter to the Editor

Lack of information as a barrier to blood donation: results from a survey of pharma industry workers in Italy

A case of dabigratan-related acute agranulocytosis

COVID-19 vaccination, anticoagulation level and warfarin treatment

Lack of influence of SARS-CoV 2 vaccination on anticoagulation levels of patients on stable, long-term warfarin treatment

Continuous population surveillance of COVID-19 immunity can be provided by Blood Services at low cost using routine laboratory infrastructure

A novel serological RhD confirmatory test for patients with warm autoimmune haemolytic anaemia with a strong positive direct antiglobulin test

Blood donor serological screening for SARS-CoV-2 as a tool to estimate the prevalence of asymptomatic infection in a low-intermediate endemic area of southern Italy after the first wave of the pandemic

Iron parenteral administration: an expert opinion on the assessment of fetal wellbeing

Organisational strategies for the safe management of intravenous iron therapy: a revolutionary tool for implementing Patient Blood Management

Making friends out of foes: novel therapeutic approaches for haemophilia

Appropriate red cell transfusions are often avoidable through Patient Blood Management

On the association between the ABO blood group and COVID-19 susceptibility

Transfusion of a D-- phenotype patient using the rare blood donor registry of the Korean Red Cross Blood Services

Haemophilia A/B carriers: haemorrhagic burden of disease and open issues

Prevalence and clinical features of COVID-19 in Iranian patients with congenital coagulation disorders

Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy

Therapeutic choices in persons with haemophilia at the time of COVID-19

Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial"

A multimodal practical approach in a Transfusion Medicine Centre to face the COVID-19 outbreak

Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial

Use of eye drops obtained from homologous blood source in the time of COVID-19: is there cause for ophthalmological concern?

Cost of Pathogen Reduction for platelets: reply to Cicchetti et al. Blood Transfus 2018; 16: 483-9

On the cost-utility of methylene blue-photoinactivated plasma versus quarantine plasma in Spain

Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis"

Reply to "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis" by Messori et al.

Preserved in vitro metabolic and functional characteristics of double-dose apheresis platelet concentrates photochemically treated with amotosalen and ultraviolet A light

Information